Alex Schwartz

Alex Schwartz began their work experience in 2008 as a Proprietary Trader at Schonfield, staying in that role until 2012. From 2013 to 2014, they pursued an MBA at Boston College. In 2015, Alex joined Stifel Financial Corp. as a Vice President and Equity Research Analyst, staying until 2018. From 2018 to 2020, they worked as a Senior Director of Investor Relations at Esperion - The Lipid Management Company. In 2020, they joined NGM Biopharmaceuticals as an Executive Director of Investor Relations. Currently, Alex serves as the Vice President of Strategic Finance and Investor Relations at Allakos Inc.

Alex Schwartz attended Indiana University - Kelley School of Business from 2004 to 2008, where they obtained a Bachelor of Science degree in Finance. Later, in 2013 and 2014, Alex completed a Master of Business Administration (MBA) program with a focus on Finance at Boston College Carroll School of Management.